NEW YORK (GenomeWeb News) – Affymetrix has named Andrew Last to be company chief operation officer and David Weber as chief commercial officer, the company said in a US Securities and Exchange Commission filing this week.

Last previously was executive VP of the firm's Genetic Analysis business unit, and Weber formerly was executive VP of global commercial operations.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

The Economist writes that an increasing number of scientific journals don't do peer review.

In Science this week: genetic overlap among many psychiatric disorders, and more.